08:00 , Feb 15, 2016 |  BioCentury  |  Finance

Imperial's diagnostic push

Imperial Innovations Group plc (LSE:IVO) is looking to put a fresh £100 million to work to follow its existing portfolio companies and create newcos, with an increasing emphasis on diagnostics and medtech. The firm...
07:00 , Jul 2, 2012 |  BC Week In Review  |  Company News

Abingdon Health, Forsite deal

Abingdon acquired an 80% stake in lateral flow diagnostic manufacturer Forsite. Abingdon said the acquisition strengthens its position as a manufacturer of rapid diagnostic tests. Forsite was spun out from the U.K.'s Food and Environment...